Warfarin use tied to bleak outcomes in ILD patients
15 Apr 2021
byJairia Dela Cruz
The use of anticoagulants, particularly warfarin, appears to convey an increased risk of death or transplant among patients with interstitial lung disease (ILD), including those with idiopathic pulmonary fibrosis, according to a study.
